Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Men
- 1 May 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 20 (5), 730-740
- https://doi.org/10.1359/jbmr.041228
Abstract
In a population-based, cross-sectional study, we related age-associated changes in vBMD and in bone structural parameters to circulating bioavailable estradiol and testosterone levels in men. Associations between these bone mass/structural parameters and sex steroid levels were progressively stronger with age. Our previously postulated "threshold" for skeletal estrogen deficiency was most evident at cortical sites. Serum sex steroids, particularly estrogen levels, are associated with bone mass in men, and previous work has suggested that there may be a "threshold" bioavailable estradiol (bio E(2)) level below which the male skeleton becomes estrogen deficient. However, previous studies addressing this issue have exclusively used DXA, which cannot separate trabecular from cortical bone or provide information on bone geometry or structure. In an age-stratified population sample of 314 men (age, 22-91 years), we assessed volumetric BMD (vBMD) and bone geometry by QCT at the lumbar spine, femoral neck, distal radius, and distal tibia and related these to circulating bio E(2) and bio testosterone (T) levels. Compared with young men (age, 20-39 years), middle-aged men (age, 40-59 years) had significantly lower bio T (-26%, p < 0.001) and bio E(2) (-9%, p = 0.038) levels, and these decreases were even greater in the elderly men (age > or = 60 years, -60% and -38% for bio T and bio E(2), respectively, p < 0.001 for both). Reflecting their intact gonadal status, vBMD/structural parameters were not related to sex steroid levels in young men, whereas bio E(2) levels were associated consistently with vBMD and variably with bone geometric parameters in the elderly men; middle-aged men showed associations with bio E(2) and bio T at some sites. At all cortical sites, vBMD was associated with bio E(2) at low ( or =30 pM, R = -0.003 to 0.12, p = not significant) levels; no such differences were evident at trabecular sites. In men, bio E(2) is the most consistent predictor of vBMD and some bone geometric variables as assessed by QCT. We also extend our previous findings on a possible "threshold" for skeletal estrogen deficiency by showing that this is most evident for cortical sites.Keywords
This publication has 27 references indexed in Scilit:
- Population-Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal SitesJournal of Bone and Mineral Research, 2004
- Bone Loss and Bone Size after MenopauseNew England Journal of Medicine, 2003
- Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2001
- Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly menJournal of Clinical Investigation, 2000
- Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo StudyJournal of Bone and Mineral Research, 1997
- Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens.Journal of Clinical Investigation, 1997
- From Density to Structure: Growing Up and Growing Old on the Surfaces of BoneJournal of Bone and Mineral Research, 1997
- The European Spine Phantom — a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCTEuropean Journal of Radiology, 1995
- Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female ratsJournal of Orthopaedic Research, 1990
- The measurement of sex steroid binding globulin by differential ammonium sulphate precipitationJournal of Steroid Biochemistry, 1973